The receiver operating curve (ROC) revealed that GPS1 had some accuracy in predicting breast cancer (AUC = 0.832, Fig. 5A) and could be used as an adjunctive diagnosis of breast cancer, but was less accurate in determining breast cancer staging (AUC < 0.7, Fig. 5B–C). This evidence concerns the gene GPS1 and breast carcinoma.